Clinical presentation of 13 children with alkaptonuria.

Until now, only a few studies have focused on the early onset of symptoms of alkaptonuria (AKU) in the pediatric population. This prospective, longitudinal study is a comprehensive approach to the assessment of children with recognized AKU during childhood. The study includes data from 32 visits of 13 patients (five males, eight females; age 4-17 years) with AKU. A clinical evaluation was performed with particular attention to eye, ear, and skin pigmentation, musculoskeletal complaints, magnetic resonance imaging (MRI), and ultrasound (US) imaging abnormalities. The cognitive functioning and adaptive abilities were examined. Molecular genetic analyses were performed. The most common symptoms observed were dark urine (13/13), followed by joint pain (6/13), and dark ear wax (6/13). In 4 of 13 patients the values obtained in the KOOS-child questionnaire were below the reference values. MRI and US did not show degenerative changes in knee cartilages. One child had nephrolithiasis. Almost half of the children with AKU (5/13) presented deficits in cognitive functioning and/or adaptive abilities. The most frequent HGD variants observed in the patients were c.481G>A (p.Gly161Arg) mutation and the c.240A>T (p.His80Gln) polymorphism. The newly described allele of the HGD gene (c.948G>T, p.Val316Phe) which is potentially pathogenic was identified. © 2023 SSIEM.

Citation

Mariusz J Kujawa, Dominik Świętoń, Jolanta Wierzba, Małgorzata Grzywińska, Oskar Budziło, Monika Limanówka, Karolina Pierzynowska, Lidia Gaffke, Łukasz Grabowski, Zuzanna Cyske, Estera Rintz, Łukasz Rąbalski, Maciej Kosiński, Grzegorz Węgrzyn, Arkadiusz Mański, Paulina Anikiej-Wiczenbach, Lakshminarayan Ranganath, Maciej Piskunowicz. Clinical presentation of 13 children with alkaptonuria. Journal of inherited metabolic disease. 2023 Sep;46(5):916-930

Mesh Tags

Substances

PMID: 37395296

search → result